{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T01:39:40Z","timestamp":1791337180908,"version":"4.3.1"},"reference-count":86,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2016,1,6]],"date-time":"2016-01-06T00:00:00Z","timestamp":1452038400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Coordination of Improvement of Higher Education Personnel (CAPES)"},{"name":"Foundation for Research of the State of Rio Grande do Sul (FAPERGS)"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurochem Res"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1007\/s11064-015-1811-y","type":"journal-article","created":{"date-parts":[[2016,1,6]],"date-time":"2016-01-06T02:10:19Z","timestamp":1452046219000},"page":"1170-1184","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Harpagophytum Procumbens Ethyl Acetate Fraction Reduces Fluphenazine-Induced Vacuous Chewing Movements and Oxidative Stress in Rat Brain"],"prefix":"10.1007","volume":"41","author":[{"given":"Larissa Finger","family":"Schaffer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catiuscia Molz","family":"de Freitas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Paula","family":"Chiapinotto Ceretta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis Ricardo","family":"Peroza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizete","family":"de Moraes Reis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e1rbara Nunes","family":"Krum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alcindo","family":"Busanello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aline Augusti","family":"Boligon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9ssie Haigert","family":"Sudati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roselei","family":"Fachinetto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,1,6]]},"reference":[{"key":"1811_CR1","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1093\/schbul\/sbt140","volume":"39","author":"HE Matar","year":"2013","unstructured":"Matar HE, Almerie MQ, Sampson S (2013) Fluphenazine (Oral) Versus Placebo for Schizophrenia. Schizophr Bull 39:1187\u20131188","journal-title":"Schizophr Bull"},{"key":"1811_CR2","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/s12272-013-0105-7","volume":"36","author":"EJ Park","year":"2013","unstructured":"Park EJ, Amatya S, Kim MS, Park JH, Seol E, Lee H, Shin Y, Hee Na D (2013) Long-acting injectable formulations of antipsychotic drugs for the treatment of schizophrenia. Arch Pharm Res 36:651\u2013659","journal-title":"Arch Pharm Res"},{"key":"1811_CR3","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1007\/s00213-014-3582-6","volume":"231","author":"J Lister","year":"2014","unstructured":"Lister J, Nobrega JN, Fletcher PJ, Remington G (2014) Oxidative stress and the antipsychotic-induced vacuous chewing movement model of tardive dyskinesia: evidence for antioxidant-based prevention strategies. Psychopharmacology 231:2237\u20132249","journal-title":"Psychopharmacology"},{"key":"1811_CR4","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/jcp.0b013e31814f1105","volume":"27","author":"AJ Loonen","year":"2007","unstructured":"Loonen AJ, Van Praag HM (2007) Measuring movement disorders in antipsychotic drug trials: the need to define a new standard. J Clin Psychopharmacol 27:423\u2013430","journal-title":"J Clin Psychopharmacol"},{"key":"1811_CR5","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S0301-0082(99)00064-7","volume":"61","author":"OA Andreassen","year":"2000","unstructured":"Andreassen OA, Jorgensen HA (2000) Neurotoxicity associated with neuroleptic induced oral dyskinesias in rats. Implications for tardive dyskinesia? Prog Neurobiol 61:525\u2013541","journal-title":"Prog Neurobiol"},{"key":"1811_CR6","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1080\/j.1440-1614.2000.00737.x","volume":"34","author":"PS Sachdev","year":"2000","unstructured":"Sachdev PS (2000) The current status of tardive dyskinesia. Aust NZ J Psychiat 34:355\u2013369","journal-title":"Aust NZ J Psychiat"},{"key":"1811_CR7","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2165\/00023210-200317010-00004","volume":"17","author":"JB Lohr","year":"2003","unstructured":"Lohr JB, Kuczenski R, Niculescu AB (2003) Oxidative mechanisms and tardive dyskinesia. CNS Drugs 17:47\u201362","journal-title":"CNS Drugs"},{"key":"1811_CR8","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1177\/0269881106062025","volume":"20","author":"GJ Paterson","year":"2006","unstructured":"Paterson GJ, Ohashi Y, Reynolds GP, Pratt JA, Morris BJ (2006) Selective increases in the cytokine, TNFalpha, in the prefrontal cortex of PCP-treated rats and human schizophrenic subjects: influence of antipsychotic drugs. J. Psychopharmacol 20:636\u2013642","journal-title":"J. Psychopharmacol"},{"key":"1811_CR9","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.ejphar.2008.06.033","volume":"590","author":"M Bishnoi","year":"2008","unstructured":"Bishnoi M, Chopra K, Kulkarni SK (2008) Activation of striatal inflammatory mediators and caspase-3 is central to haloperidol-induced orofacial dyskinesia. Eur J Pharmacol 590:241\u2013245","journal-title":"Eur J Pharmacol"},{"key":"1811_CR10","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.pbb.2007.10.009","volume":"88","author":"M Bishnoi","year":"2008","unstructured":"Bishnoi M, Chopra K, Kulkarni SK (2008) Protective effect of Curcumin, the active principle of turmeric (Curcuma longa) in haloperidol-induced orofacial dyskinesia and associated behavioural, biochemical and neurochemical changes in rat brain. Pharmacol Biochem Behav 88:511\u2013522","journal-title":"Pharmacol Biochem Behav"},{"key":"1811_CR11","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/S0028-3908(03)00314-9","volume":"45","author":"YS Lau","year":"2003","unstructured":"Lau YS, Petroske E, Meredith GE, Wang JQ (2003) Elevated neuronal nitric oxide synthase expression in chronic haloperidol-treated rats. Neuropharmacology 45:986\u2013994","journal-title":"Neuropharmacology"},{"issue":"3","key":"1811_CR12","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.pbb.2005.05.002","volume":"81","author":"ME Burger","year":"2005","unstructured":"Burger ME, Fachinetto R, Zeni G, Rocha JB (2005) Ebselen\u00a0attenuates\u00a0haloperidollnduced\u00a0orofacial\u00a0dyskinesia\u00a0and\u00a0oxidative\u00a0stress\u00a0in\u00a0rat\u00a0brain. Pharmacol Biochem Behav 81(3):608\u2013615","journal-title":"Pharmacol Biochem Behav"},{"key":"1811_CR13","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s00213-007-0831-y","volume":"194","author":"R Fachinetto","year":"2007","unstructured":"Fachinetto R, Villarinho JG, Wagner C, Pereira RP, Puntel RL, Paix\u00e3o MW, Braga AL, Calixto JB, Rocha JB, Ferreira J (2007) Diphenyl diselenide decreases the prevalence of vacuous chewing movements induced by fluphenazine in rats. Psychopharmacology 194:423\u2013432","journal-title":"Psychopharmacology"},{"key":"1811_CR14","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3109\/13880200903029357","volume":"48","author":"VS Nade","year":"2010","unstructured":"Nade VS, Kawale LA, Yadav AV (2010) Protective effect of Morus alba leaves on haloperidol-induced orofacial dyskinesia and oxidative stress. Pharm Biol 48:17\u201322","journal-title":"Pharm Biol"},{"key":"1811_CR15","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.brainres.2011.07.014","volume":"1412","author":"RP Daya","year":"2011","unstructured":"Daya RP, Tan ML, Sookram CD, Skoblenick K, Mishra RK (2011) Alpha-phenyl-N-tert-butylnitrone prevents oxidative stress in a haloperidol-induced animal model of tardive dyskinesia: investigating the behavioural and biochemical changes. Brain Res 1412:28\u201336","journal-title":"Brain Res"},{"key":"1811_CR16","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.pbb.2012.01.007","volume":"101","author":"A Busanello","year":"2012","unstructured":"Busanello A, Peroza LR, Wagner C, Sudati JH, Pereira RP, Prestes Ade S, Rocha JB, Fachinetto R, Barbosa NB (2012) Resveratrol reduces vacuous chewing movements induced by acute treatment with fluphenazine. Pharmacol Biochem Behav 101:307\u2013310","journal-title":"Pharmacol Biochem Behav"},{"key":"1811_CR17","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1007\/s11064-013-0981-8","volume":"38","author":"LR Peroza","year":"2013","unstructured":"Peroza LR, Busanello A, Leal CQ, R\u00f6pke J, Boligon AA, Meinerz D, Libardoni M, Athayde ML, Fachinetto R (2013) Bauhinia forficata prevents vacuous chewing movements induced by haloperidol in rats and has antioxidant potential in vitro. Neurochem Res 38:789\u2013796","journal-title":"Neurochem Res"},{"key":"1811_CR18","first-page":"47","volume":"50","author":"T Wegener","year":"2000","unstructured":"Wegener T (2000) Devil\u2019s Claw: from African traditional remedy to modern analgesic and antiinflammatory. Herbal Gram 50:47\u201354","journal-title":"Herbal Gram"},{"key":"1811_CR19","first-page":"155","volume":"13","author":"N Gericke","year":"2012","unstructured":"Gericke N (2012) Plants, products and people\u201d Southern African perspectives. Ethnomed Drug Discov 13:155\u2013162","journal-title":"Ethnomed Drug Discov"},{"key":"1811_CR20","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/ptr.2029","volume":"21","author":"L Grant","year":"2007","unstructured":"Grant L, McBean DE, Fyfe L, Warnock AM (2007) A Review of the biological and potential therapeutic actions of Harpagophytum procumbens. Phytother Res 21:199\u2013209","journal-title":"Phytother Res"},{"key":"1811_CR21","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.jep.2012.08.013","volume":"143","author":"N Mncwangi","year":"2012","unstructured":"Mncwangi N, Chen W, Vermaak I, Viljoen AM, Gericke N (2012) Devil\u2019s Claw\u2014a review of the ethnobotany, phytochemistry and biological activity of Harpagophytum procumbens. J Ethnopharm 143:755\u2013771","journal-title":"J Ethnopharm"},{"issue":"10","key":"1811_CR22","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1002\/ptr.1322","volume":"17","author":"T Wegener","year":"2003","unstructured":"Wegener T, Lupke NP (2003) Treatment of patients with arthrosis of hip or knee with an aqueous extract of devil\u2019s claw (Harpagophytum procumbens DC. Phytother Res 17(10):1165\u20131172","journal-title":"Phytother Res"},{"key":"1811_CR23","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1002\/ptr.1593","volume":"18","author":"IM Mahomed","year":"2004","unstructured":"Mahomed IM, Ojewole JAO (2004) Analgesic, antiinflammatory and antidiabetic properties of Harpagophytum procumbens DC (Pedaliaceae) secondary root aqueous extract. Phytother Res 18:982\u2013989","journal-title":"Phytother Res"},{"key":"1811_CR24","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.canlet.2004.07.029","volume":"218","author":"J-K Kundu","year":"2005","unstructured":"Kundu J-K, Mossanda KS, Na HK, Surh YJ (2005) Inhibitory effects of the extracts of Sutherlandia frutescens (L.) R.Br.and Harpagophytum procumbens DC. On phorbolester-induced COX-2 expression in mouse skin: AP-1 and CREB as potential upstream targets. Cancer Lett 218:21\u201331","journal-title":"Cancer Lett"},{"key":"1811_CR25","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jep.2005.08.055","volume":"104","author":"TH Huang","year":"2006","unstructured":"Huang TH, Tran VH, Duke RK, Tan S, Chrubasik S, Roufogalis BD, Duke CC (2006) Harpagoside suppresses lipopolysaccharide-induced iNOS and COX-2 expression through inhibition of NF-\u03baB activation. J Ethnopharmacol 104:149\u2013155","journal-title":"J Ethnopharmacol"},{"key":"1811_CR26","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1002\/ptr.2288","volume":"21","author":"M Warnock","year":"2007","unstructured":"Warnock M, McBean D, Suter A, Tan J, Whittaker P (2007) Effectiveness and safety of devil\u2019s claw tablets in patients with general rheumatic disorders. Phytoter Res 21:1228\u20131233","journal-title":"Phytoter Res"},{"issue":"6","key":"1811_CR27","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1002\/ptr.3636","volume":"26","author":"BL Fiebich","year":"2011","unstructured":"Fiebich BL, Mu\u00f1oz E, Rose T, Weiss G, McGregor GP (2011) Molecular targets of the antiinflammatory Harpagophytum procumbens (Devil\u2019s claw): inhibition of TNFa and COX-2 gene expression by preventing activation of AP-1. Phytother Res 26(6):806\u2013811","journal-title":"Phytother Res"},{"issue":"8","key":"1811_CR28","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1002\/ptr.3410","volume":"25","author":"L Wachsmuth","year":"2011","unstructured":"Wachsmuth L, Lindhorst E, Wrubel S, Hadzhiyski H, Hudelmaier M, Eckstein F, Chrubasik S (2011) Micro-morphometrical assessment of the effect of Harpagophytum procumbens extract on articular cartilage inrabbits with experimental osteoarthritis using magnetic resonance imaging. Phytother Res 25(8):1133\u20131140","journal-title":"Phytother Res"},{"key":"1811_CR29","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1055\/s-2003-42778","volume":"69","author":"C Clarkson","year":"2003","unstructured":"Clarkson C, Campbell WE, Smith P (2003) In vitro antiplasmodial activity of abietane and totarane diterpenes isolated from Harpagophytum procumbens (Devil\u2019s Claw). Planta Med 69:720\u2013724","journal-title":"Planta Med"},{"key":"1811_CR30","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.brainresbull.2005.10.010","volume":"69","author":"IM Mahomed","year":"2006","unstructured":"Mahomed IM, Ojewole JAO (2006) Anticonvulsant activity of Harpagophytum procumbens DC [Pedaliaceae] secondary root aqueous extract in mice. Brain Res Bull 69:57\u201362","journal-title":"Brain Res Bull"},{"key":"1811_CR31","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1540\/jsmr.45.231","volume":"45","author":"IM Mahomed","year":"2009","unstructured":"Mahomed IM, Ojewole JAO (2009) Uterotonic effect of Harpagophytum procumbens DC (Pedaliaceae) secondary root aqueous extract on rat isolated uterine horns. J Smooth Muscle Res 45:231\u2013239","journal-title":"J Smooth Muscle Res"},{"key":"1811_CR32","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1248\/bpb.31.240","volume":"31","author":"S Uchida","year":"2008","unstructured":"Uchida S, Hirai K, Hatanaka J, Hanato J, Umegaki K, Yamada S (2008) Antinociceptive effects of St. John\u2019s Wort, Harpagophytum Procumbens extract and grape seed proanthocyanidins extract in mice. Biol Pharm Bull 31:240\u2013245","journal-title":"Biol Pharm Bull"},{"key":"1811_CR33","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/ptr.3555","volume":"26","author":"MI Georgiev","year":"2012","unstructured":"Georgiev MI, Alipieva K, Orhan IE (2012) Cholinesterases inhibitory and antioxidant activities of Harpagophytum procumbens from in vitro systems. Phytother Res 26:313\u2013316","journal-title":"Phytother Res"},{"key":"1811_CR34","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1007\/s11064-013-1133-x","volume":"38","author":"LF Schaffer","year":"2013","unstructured":"Schaffer LF, Peroza LR, Boligon AA, Athayde ML, Alves SH, Fachinetto R, Wagner C (2013) Harpagophytum procumbens prevents oxidative stress and loss of cell viability in vitro. Neurochem Res 38:2256\u20132267","journal-title":"Neurochem Res"},{"issue":"9","key":"1811_CR35","doi-asserted-by":"crossref","first-page":"16758","DOI":"10.3390\/molecules200916758","volume":"20","author":"C Parenti","year":"2013","unstructured":"Parenti C, Aric\u00f2 G, Chiechio S, Di Benedetto G, Parenti R, Scoto GM (2015) Involvement of the heme-oxygenase pathway in the antiallodynic and antihyperalgesic activity of Harpagophytum procumbens in rats. Molecules 20(9):16758\u201316769","journal-title":"Molecules"},{"key":"1811_CR36","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1111\/j.1471-4159.2011.07635.x","volume":"120","author":"X Sun","year":"2012","unstructured":"Sun X, Xiong Z, Zhang Y, Meng Y, Xu G, Xia Z, Li J, Zhang R, Ke Z, Xia Z, Hu Y (2012) Harpagoside attenuates MPTP\/MPP induced dopaminergic neurodegeneration and movement disorder via elevating glial cell line-derived neurotrophic factor. J Neurochem 120:1072\u20131083","journal-title":"J Neurochem"},{"key":"1811_CR37","first-page":"2","volume":"5","author":"A Bhattacharya","year":"1998","unstructured":"Bhattacharya A, Bhattacharya S (1998) Anti-oxidant activity of Harpagophytum procumbens. Br J Phytother 5:2","journal-title":"Br J Phytother"},{"key":"1811_CR38","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.neulet.2008.04.058","volume":"438","author":"HW Liang","year":"2008","unstructured":"Liang HW, Qiu SF, Shen J, Sun LN, Wang JY, Bruce IC, Xia Q (2008) Genistein attenuates oxidative stress and neuronal damage following transient global cerebral ischemia in rat hippocampus. Neurosci Lett 438:116\u2013120","journal-title":"Neurosci Lett"},{"key":"1811_CR39","doi-asserted-by":"crossref","first-page":"175","DOI":"10.4103\/0973-1296.96587","volume":"8","author":"FE Babili","year":"2012","unstructured":"Babili FE, Fouraste I, Rougaignon C, Moulis C, Chatelain C (2012) Anatomical study of secondary tuberized roots of Harpagophytum procumbens DC and quantification of harpagoside by high-performance liquid chromatography method. Pharmacogn Mag 8:175\u2013180","journal-title":"Pharmacogn Mag"},{"key":"1811_CR40","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1007\/s11738-013-1259-0","volume":"35","author":"AA Boligon","year":"2013","unstructured":"Boligon AA, Kubi\u00e7a TF, Mario DN, Brum TF, Piana M, Weiblen R, Lovato L, Alves SH, Santos RCV, Alves CFS, Athayde ML (2013) Antimicrobial and antiviral activity-guided fractionation from Scutia buxifolia Reissek extracts. Acta Physiol Plant 35:2229\u20132239","journal-title":"Acta Physiol Plant"},{"key":"1811_CR41","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/S0168-9452(02)00332-1","volume":"153","author":"CW Choi","year":"2002","unstructured":"Choi CW, Kim SC, Hwang SS, Choi BK, Ahn HJ, Lee MY, Paerk SH, Kim SK (2002) Antioxidant activity and free radical scavenging capacity between Korean medicinal plants and flavonoids by assay-guided comparison. Plant Sci 153:1161\u20131168","journal-title":"Plant Sci"},{"key":"1811_CR42","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0306-4522(00)00412-7","volume":"101","author":"JM Kampen Van","year":"2000","unstructured":"Van Kampen JM, Stoessl AJ (2000) Dopamine D1A receptor function in a rodent model of tardive dyskinesia. Neuroscience 101:629\u2013635","journal-title":"Neuroscience"},{"key":"1811_CR43","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1139\/y94-220","volume":"72","author":"R Soulimani","year":"1994","unstructured":"Soulimani R, Younos C, Mortier F, Derrieu C (1994) The role of stomachal digestion on the pharmacological activity of plant extracts, using as an example, extracts of Harpagophytum procumbens. Can J Physiol Pharmacol 72:1532\u20131536","journal-title":"Can J Physiol Pharmacol"},{"key":"1811_CR44","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0944-7113(00)80076-8","volume":"6","author":"S Chrubasik","year":"2000","unstructured":"Chrubasik S, Sporer F, Dillmann-Marschner R, Friedmann A, Wink M (2000) Physicochemical properties of harpagoside and its in vitro release from Harpagophytum procumbens extract tablets. Phytomedicine 6:469\u2013473","journal-title":"Phytomedicine"},{"key":"1811_CR45","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1016\/j.pnpbp.2007.06.028","volume":"31","author":"R Fachinetto","year":"2007","unstructured":"Fachinetto R, Villarinho JG, Wagner C, Pereira RP, Avila DS, Burger ME, Calixto JB, Rocha JB, Ferreira J (2007) Valeriana officinalis does not alter the orofacial dyskinesia induced by haloperidol in rats: role of dopamine transporter. Prog Neuropsychopharmacol Biol Psychiatry 31:1478\u20131486","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"3","key":"1811_CR46","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.pbb.2005.05.001","volume":"81","author":"R Fachinetto","year":"2005","unstructured":"Fachinetto R, Burger ME, Wagner C, Wondracek DC, Brito VB, Nogueira CW, Ferreira J, Rocha JB (2005) High\u00a0fat\u00a0diet\u00a0increases\u00a0the\u00a0incidence\u00a0of\u00a0orofacial dyskinesia\u00a0and\u00a0oxidative\u00a0stress\u00a0in\u00a0specific\u00a0brain\u00a0regions\u00a0of\u00a0rats. Pharmacol Biochem Behav 81(3):585\u2013592","journal-title":"Pharmacol Biochem Behav"},{"issue":"1","key":"1811_CR47","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/FBP.0b013e328341e9b4","volume":"22","author":"A Busanello","year":"2011","unstructured":"Busanello A, Barbosa NB, Peroza LR, Farias LE, Burger ME, Barreto KP, Fachinetto R (2011) Resveratrol protects against a model of vacuous chewing movements induced by reserpine in mice. Behav Pharmacol 22(1):71\u201375","journal-title":"Behav Pharmacol"},{"key":"1811_CR48","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.pbb.2013.01.001","volume":"104","author":"P Reckziegel","year":"2013","unstructured":"Reckziegel P, Peroza LR, Schaffer LF, Ferrari MC, Freitas CM, B\u00fcrger ME, Fachinetto R (2013) Gallic acid decreases vacuous chewing movements induced by reserpine in rats Pharmacology. Biochem Behav 104:132\u2013137","journal-title":"Biochem Behav"},{"issue":"54","key":"1811_CR49","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.pnpbp.2014.04.006","volume":"3","author":"J R\u00f6pke","year":"2014","unstructured":"R\u00f6pke J, Busanello A, Leal CQ, de Moraes Reis E, de Freitas CM, Villarinho JG, Figueira FH, Mello CF, Ferreira J, Fachinetto R (2014) Anandamide attenuates haloperidol-induced vacuous chewing movements in rats. Prog Neuropsychopharmacol Biol Psychiatry 3(54):195\u2013199","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"1811_CR50","first-page":"76","volume-title":"Experiments in personality","author":"PL Broadhurst","year":"1960","unstructured":"Broadhurst PL (1960) Experiments in psychogenetics. In: Eysenk HJ (ed) Experiments in personality. Routledge & Kegan Paul, London, p 76"},{"key":"1811_CR51","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/0003-2697(79)90738-3","volume":"95","author":"H Ohkawa","year":"1979","unstructured":"Ohkawa H, Ohishi H, Yagi K (1979) Assay for lipid peroxide in animal tissues by thiobarbituric acid reaction. Anal Biochem 95:351\u2013358","journal-title":"Anal Biochem"},{"key":"1811_CR52","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/0003-9861(59)90090-6","volume":"82","author":"GL Ellman","year":"1959","unstructured":"Ellman GL (1959) Tissue sulfhydryl groups. Arch Biochem Biophys 82:70\u201377","journal-title":"Arch Biochem Biophys"},{"key":"1811_CR53","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/j.neuint.2004.06.008","volume":"45","author":"F P\u00e9rez-Severiano","year":"2004","unstructured":"P\u00e9rez-Severiano F, Rodr\u00edguez-P\u00e9rez M, Pedraza-Chaverr\u00ed J, Maldonado PD, Medina-Campos ON, Ort\u00edz-Plata A, S\u00e1nchez-Garc\u00eda A, Villeda-Hern\u00e1ndez J, Galv\u00e1n-Arzate S, Aguilera P, Santamar\u00eda A (2004) S-Allylcysteine, a garlic-derived antioxidant, ameliorates quinolinic acid-induced neurotoxicity and oxidative damage in rats. Neurochem Int 45:1175\u20131183","journal-title":"Neurochem Int"},{"key":"1811_CR54","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0076-6879(84)05016-3","volume":"105","author":"H Aebi","year":"1984","unstructured":"Aebi H (1984) Catalase in vitro\u2016 on antioxidative defenses. Methods Enzymol 105:121\u2013127","journal-title":"Methods Enzymol"},{"key":"1811_CR55","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","volume":"193","author":"OH Lowry","year":"1951","unstructured":"Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265\u2013275","journal-title":"J Biol Chem"},{"key":"1811_CR56","first-page":"405","volume":"36","author":"S Frangou","year":"2008","unstructured":"Frangou S (2008) Schizophrenia. Psychiatric disorders 36:405\u2013409","journal-title":"Psychiatric disorders"},{"key":"1811_CR57","first-page":"1","volume":"13","author":"S Alabed","year":"2011","unstructured":"Alabed S, Latifeh Y, Mohammad HA, Rifai A (2011) Gamma-aminobutyric acid agonists for neuroleptic-induced tardive dyskinesia. Cochrane Database Syst Rev 13:1\u201340","journal-title":"Cochrane Database Syst Rev"},{"key":"1811_CR58","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1002\/ptr.898","volume":"15","author":"D Laudahn","year":"2001","unstructured":"Laudahn D, Walper A (2001) Efficacy and tolerance of Harpagophytum Extract LI 174 in patients with chronic non-radicular back pain. Phytother Res 15:621\u2013624","journal-title":"Phytother Res"},{"key":"1811_CR59","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1002\/ptr.2570","volume":"23","author":"L Grant","year":"2009","unstructured":"Grant L, McBean DE, Fyfe L, Warnock AM (2009) The inhibition of free radical generation by preparations of Harpagophytum procumbens In Vitro. Phytother Res 23:104\u2013110","journal-title":"Phytother Res"},{"key":"1811_CR60","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.jep.2005.07.004","volume":"100","author":"KM Stewart","year":"2005","unstructured":"Stewart KM, Cole D (2005) The commercial harvest of Devil\u2019s Claw (Harpagophytum spp.) in southern Africa: the devil\u2019s in the details. J Ethnopharmcol 100:225\u2013236","journal-title":"J Ethnopharmcol"},{"key":"1811_CR61","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.chroma.2004.09.002","volume":"1073","author":"AH Schimidt","year":"2005","unstructured":"Schimidt AH (2005) Fast HPLC for quality control of Harpagophytum procumbens by using a monolithic silica column: method transfer from conventional particle-based silica column. J Chromatoqr 1073:377\u2013381","journal-title":"J Chromatoqr"},{"key":"1811_CR62","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1055\/s-2008-1074500","volume":"74","author":"N Abdelouahad","year":"2008","unstructured":"Abdelouahad N, Head C (2008) Dermal and transcutaneous delivery of the major glycoside constituents of Harpagophytum procumbens (Devil\u2019s Claw) in vitro. Planta Med 74:527\u2013531","journal-title":"Planta Med"},{"key":"1811_CR63","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/0891-5849(95)02227-9","volume":"20","author":"CA Rice-Evans","year":"1996","unstructured":"Rice-Evans CA, Miller NJ, Paganga G (1996) Structure\u2013antioxidant activity relationships of flavonoids and phenolic acids. Free Radic Biol Med 20:933\u2013956","journal-title":"Free Radic Biol Med"},{"key":"1811_CR64","doi-asserted-by":"crossref","first-page":"6592","DOI":"10.1016\/j.biortech.2009.03.091","volume":"100","author":"AA Boligon","year":"2009","unstructured":"Boligon AA, Pereira RP, Feltrin AC, Machado MM, Janovik V, Rocha JB, Athayde ML (2009) Antioxidant activities of flavonol derivatives from the leaves and stem bark of Scutia buxifolia Reiss. Bioresour Technol 100:6592\u20136598","journal-title":"Bioresour Technol"},{"key":"1811_CR65","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1007\/s12017-008-8037-y","volume":"10","author":"TG Son","year":"2008","unstructured":"Son TG, Camandola S, Mattson MP (2008) Hormetic dietary phytochemicals. Neuromolecular Med 10:236\u2013246","journal-title":"Neuromolecular Med"},{"issue":"9","key":"1811_CR66","doi-asserted-by":"crossref","first-page":"e0139298","DOI":"10.1371\/journal.pone.0139298","volume":"10","author":"J Bao","year":"2015","unstructured":"Bao J, Huang B, Zou L, Chen S, Zhang C, Zhang Y, Chen M, Wan JB, Su H, Wang Y, He C (2015) Hormetic effect of berberine attenuates the anticancer activity of chemotherapeutic agents. PlosOne 10(9):e0139298. doi: 10.1371\/journal.pone.0139298","journal-title":"PlosOne"},{"key":"1811_CR67","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.taap.2007.02.015","volume":"222","author":"EJ Calabrese","year":"2007","unstructured":"Calabrese EJ, Bachmann KA, Bailer AJ, Bolger PM, Borak J et al (2007) Biological stress response terminology: integrating the concepts of adaptive response and preconditioning stress within a hormetic dose-response framework. Toxicol Appl Pharmacol 222:122\u2013128","journal-title":"Toxicol Appl Pharmacol"},{"issue":"Suppl 4","key":"1811_CR68","first-page":"5","volume":"61","author":"DE Casey","year":"2000","unstructured":"Casey DE (2000) Tardive dyskinesia: pathophysiology and animal models. J Clin Psychiat 61(Suppl 4):5\u20139","journal-title":"J Clin Psychiat"},{"key":"1811_CR69","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0149-7634(02)00008-8","volume":"26","author":"P Turrone","year":"2002","unstructured":"Turrone P, Remington G, Nobrega JN (2002) The vacuous chewing movement (VCM) model of tardive dyskinesia revisited: is there a relationship to dopamine D2 receptor occupancy? Neurosci Biobehav 26:361\u2013380","journal-title":"Neurosci Biobehav"},{"key":"1811_CR70","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1126\/science.17917","volume":"197","author":"P Lerner","year":"1977","unstructured":"Lerner P, Nose P, Gordon EK, Lovenberg W (1977) Haloperidol: effect of long-term treatment on rat striatal dopamine synthesis and turnover. Science 197:181\u2013183","journal-title":"Science"},{"key":"1811_CR71","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1073\/pnas.86.4.1398","volume":"86","author":"MB Spina","year":"1989","unstructured":"Spina MB, Cohen G (1989) Dopamine turnover and glutathione oxidation: implications for Parkinson disease. Proc Nat Acad Sci USA 86:1398\u20131400","journal-title":"Proc Nat Acad Sci USA"},{"key":"1811_CR72","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1002\/syn.20078","volume":"54","author":"RM Rogoza","year":"2004","unstructured":"Rogoza RM, Fairfax DF, Henry P, N-Marandi S, Khan RF, Gupta SK, Mishra RK (2004) Electron spin resonance spectroscopy reveals alpha-phenyl-N-tert-butylnitrone spin-traps free radicals in rat striatum and prevents haloperidol-induced vacuous chewing movements in the rat model of human tardive dyskinesia. Synapse 54:156\u2013163","journal-title":"Synapse"},{"key":"1811_CR73","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/0006-3223(90)90490-S","volume":"28","author":"JB Lohr","year":"1990","unstructured":"Lohr JB, Kuczenski R, Bracha HS, Moir M, Jeste DV (1990) Increased indices of free radical activity in the cerebrospinal fluid of patients with tardive dyskinesia. Biol Psychiatry 28:535\u2013539","journal-title":"Biol Psychiatry"},{"key":"1811_CR74","first-page":"1744","volume":"1721","author":"L Tsai","year":"1995","unstructured":"Tsai L, Ikonomidou C (1995) Toward an understanding of tardive dyskinesia: chronic haloperidol enhances NMDA toxicity in mouse striatum. Soc Neurosci Abstr 1721:1744","journal-title":"Soc Neurosci Abstr"},{"key":"1811_CR75","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/S0006-3223(97)00197-2","volume":"43","author":"K Brown","year":"1998","unstructured":"Brown K, Reid A, White T, Hukin S, Jonhstone C, Glen A (1998) Vitamin E, lipids, and lipid peroxidation products in tardive dyskinesia. Biol Psychiatry 43:863\u2013867","journal-title":"Biol Psychiatry"},{"key":"1811_CR76","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.biopsych.2013.03.018","volume":"74","author":"J Flatow","year":"2013","unstructured":"Flatow J, Buckley P, Miller BJ (2013) Meta-analysis of oxidative stress in schizophrenia. Biol Psychiat 74:400\u2013409","journal-title":"Biol Psychiat"},{"key":"1811_CR77","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/1471-244X-13-152","volume":"13","author":"RM Merrill","year":"2013","unstructured":"Merrill RM, Lyon JL, Matiaco PM (2013) Tardive and spontaneous dyskinesia in the general population. BMC Psychiatry 13:152","journal-title":"BMC Psychiatry"},{"key":"1811_CR78","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1176\/ajp.149.6.773","volume":"149","author":"MF Egan","year":"1992","unstructured":"Egan MF, Hyde TM, Albers GW, Elkashef A, Alexander RC, Reeve A, Blum A, Saenz RE, Wyatt RJ (1992) Treatment of tardive dyskinesia with vitamin E. Am J Psychiatry 149:773\u2013777","journal-title":"Am J Psychiatry"},{"key":"1811_CR79","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1176\/ajp.150.9.1405","volume":"150","author":"LA Adler","year":"1993","unstructured":"Adler LA, Peselow E, Rotrosen J, Duncam E, Lee M, Rosenthal BA, Angrist B (1993) Vitamine E treatment of tardive dyskinesia. Am J Psychiatry 150:1405\u20131407","journal-title":"Am J Psychiatry"},{"key":"1811_CR80","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1080\/14786410902819087","volume":"25","author":"AA Pathan","year":"2011","unstructured":"Pathan AA, Mohan M, Kasture AS, Kasture SB (2011) Mucuna pruriens attenuates haloperidol-induced orofacial dyskinesia in rats. Nat Prod Res 25:764\u2013771","journal-title":"Nat Prod Res"},{"key":"1811_CR81","doi-asserted-by":"crossref","first-page":"691","DOI":"10.3109\/13880209.2011.618841","volume":"50","author":"R Patil","year":"2012","unstructured":"Patil R, Hiray Y, Shinde S, Langade P (2012) Reversal of haloperidolinduced orofacial dyskinesia by Murraya koenigii leaves in experimental animals. Pharm Biol 50:691\u2013697","journal-title":"Pharm Biol"},{"key":"1811_CR82","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/S0278-6915(99)00090-3","volume":"37","author":"J Chaudi\u00e8re","year":"1999","unstructured":"Chaudi\u00e8re J, Ferrari-iliou R (1999) Intracellular antioxidants: from chemical to biochemical mechanisms. Food Chem Toxicol 37:949\u2013962","journal-title":"Food Chem Toxicol"},{"key":"1811_CR83","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/0163-7258(89)90069-7","volume":"44","author":"EJ Calabrese","year":"1989","unstructured":"Calabrese EJ, Canada AT (1989) Catalase: its role in xenobiotic detoxification. Pharmac Ther 44:297\u2013307","journal-title":"Pharmac Ther"},{"key":"1811_CR84","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.bbr.2012.03.008","volume":"231","author":"VS Fernandes","year":"2012","unstructured":"Fernandes VS, Santos JR, Le\u00e3o AHFF, Medeiros AM, Melo TG, Iz\u00eddio GS, Cabral A, Ribeiro RA, Ab\u00edlio VC, Ribeiro AM, Silva RH (2012) Repeated treatment with a low dose of reserpine as a progressive model of Parkinson\u2019s disease. Behav Brain Res 231:154\u2013163","journal-title":"Behav Brain Res"},{"key":"1811_CR85","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1007\/BF00589906","volume":"99","author":"AE Kelley","year":"1989","unstructured":"Kelley AE, Bakshi VP, Delfs JM, Lang CG (1989) Cholinergic stimulation of the ventrolateral striatum elicits mouth movements in rats: pharmacological and regional specificity. Psychopharmacology 99:542\u2013549","journal-title":"Psychopharmacology"},{"issue":"Suppl","key":"1811_CR86","doi-asserted-by":"crossref","first-page":"S130","DOI":"10.1016\/j.parkreldis.2008.04.017","volume":"2","author":"JD Salamone","year":"2008","unstructured":"Salamone JD, Ishiwari K, Betz AJ, Farrar AM, Mingote SM, Font L, Hockemeyer J, M\u00fcller CE, Correa M (2008) Dopamine\/adenosine interactions related to locomotion and tremor in animal models: possible relevance to parkinsonism. Parkinsonism Relat Disord 2(Suppl):S130\u2013S134","journal-title":"Parkinsonism Relat Disord"}],"container-title":["Neurochemical Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-015-1811-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11064-015-1811-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-015-1811-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T16:52:54Z","timestamp":1718297574000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11064-015-1811-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,6]]},"references-count":86,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["1811"],"URL":"https:\/\/doi.org\/10.1007\/s11064-015-1811-y","relation":{},"ISSN":["0364-3190","1573-6903"],"issn-type":[{"value":"0364-3190","type":"print"},{"value":"1573-6903","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,6]]}}}